Tuesday April 1, 2014
Aurobindo Pharma on Tuesday said it has completed acquisition of certain commercial operations of Actavis Plc in Western Europe.
Thursday March 27, 2014
Pharma and IT stocks have been the big outperformers in the Indian markets for the last many months, but clearly investors' interest in these stocks is waning. The reasons are not difficult to guess.
Friday February 7, 2014
Aurobindo Pharma posted a four-fold increase in profit to Rs 417 crore for the December quarter, beating some analysts estimates.
Saturday January 18, 2014
Generic drug maker Aurobindo Pharma has signed a binding offer agreement to acquire commercial operations of Dublin-based Actavis Plc in seven Western European countries.
Sunday January 12, 2014
Pharmaceutical companies may witness a core sales growth of 26 per cent in the third quarter of fiscal year 2014, according to a report by Bank of America-Merrill Lynch.
Thursday December 26, 2013
Wockhardt was up 2.2 per cent, heading for its sixth daily gain in the past seven sessions for a total gain of 28 per cent so far during that period.
Wednesday December 18, 2013
The shares of Biocon surged today after the biotechnology company entered into an agreement with Quark Pharmaceuticals for development of a new range of therapeutics.
Thursday December 12, 2013
Aurobindo Pharma, Dr Reddy's Laboratories, Lupin, Sun Pharma Global FZE, and Torrent Pharmaceuticals have received the regulatory nod to market duloxetine in various strengths, besides Teva Pharmaceuticals, USA, says a press release issued by the FDA...
Thursday November 7, 2013
The company's total income from operations increased by 27.6 per cent to Rs 1,913.9 crore in the second quarter (Q2) of this fiscal compared to Rs 1,500.4 crore in the same period last fiscal, Aurobindo Pharma said in a statement.
Friday August 9, 2013
Net Q1 sales of the company rose to Rs 1,699.60 crore, as against Rs 1,197.44 crore during the same period of the previous fiscal, Aurobindo Pharma said in a statement.
Sunday July 28, 2013
The US Food and Drug Administration (FDA) also warned of "appropriate action" against the companies who fail to implement "Good Manufacturing Practices".
Monday July 22, 2013
According to a petition filed by UCB Inc, UCB Pharma GMBH, Research Corporation Technologies, Inc and Harris FRC Corporation the patent of its drug Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg would expire on March 17, 2022.
Saturday May 4, 2013
Aurobindo Pharma said on Saturday that it has received final approvals from US health regulator to sell generic versions of two separate drugs used for treatment of enlarged prostate and bacterial infections in infants.
Monday June 24, 2013
The week ahead should see the markets react to key March inflation data on Monday and Reliance results due on Tuesday. The Nifty is very critically placed at key support levels of 5500, any breach of which can trigger a wave of selling. With pessimis...
Monday June 24, 2013
The week ahead should see the stock markets bounce back after being heavily oversold in the short term. Fall in oil prices, expectation of good results and fall in bond yields will likely help markets rally next week.
Wednesday April 3, 2013
Drug firm Aurobindo Pharma today said it has received tentative approval from the US health regulator to manufacture and market its anti-AIDS combination drug Efavirenz/Emtricitabine and Tenofovir Disoproxil Fumarate tablets in the American market.
Thursday March 28, 2013
Aurobindo Pharma today said the US health regulator has lifted the import alert on its Hyderabad-based antibiotics facility, thereby allowing the company to export 9 products from this plant to the US market.
Thursday March 28, 2013
The stock markets are off the days low, outperforming global peers, as buying pace picked up in the second half of the day.
Wednesday February 27, 2013
Shares in Jubilant Life Sciences Ltd fell as much as 6.9 per cent on Wednesday after the US health regulator issued a warning letter to the company, citing "significant violations" of manufacturing standards at its facility in Canada.
Friday February 22, 2013
Aurobindo Pharma is preparing to challenge before the Appellate Tribunal an order that allowed Enforcement Directorate (ED) to take possession of attached property and fixed deposits worth Rs 12.90 crore in connection with money laundering probe agai...